Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Cochlear Yönetim

Yönetim kriter kontrolleri 4/4

Cochlear's CEO'su Dig Howitt, Jul2017 tarihinde atandı, in görev süresi 7.25 yıldır. in toplam yıllık tazminatı A$ 6.45M olup, şirket hissesi ve opsiyonları dahil olmak üzere 32.1% maaş ve 67.9% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.094% ine doğrudan sahiptir ve bu hisseler $ 12.33M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.3 yıl ve 4.8 yıldır.

Anahtar bilgiler

Dig Howitt

İcra Kurulu Başkanı

AU$6.4m

Toplam tazminat

CEO maaş yüzdesi	32.1%
CEO görev süresi	7.3yrs
CEO sahipliği	0.09%
Yönetim ortalama görev süresi	7.3yrs
Yönetim Kurulu ortalama görev süresi	4.8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Dig Howitt'un ücretlendirmesi Cochlear'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	AU$6m	AU$2m	AU$357m
Mar 31 2024	n/a	n/a	AU$354m
Dec 31 2023	n/a	n/a	AU$350m
Sep 30 2023	n/a	n/a	AU$326m
Jun 30 2023	AU$6m	AU$2m	AU$301m
Mar 31 2023	n/a	n/a	AU$281m
Dec 31 2022	n/a	n/a	AU$261m
Sep 30 2022	n/a	n/a	AU$275m
Jun 30 2022	AU$5m	AU$2m	AU$289m
Mar 31 2022	n/a	n/a	AU$273m
Dec 31 2021	n/a	n/a	AU$257m
Sep 30 2021	n/a	n/a	AU$291m
Jun 30 2021	AU$5m	AU$2m	AU$324m
Mar 31 2021	n/a	n/a	AU$82m
Dec 31 2020	n/a	n/a	-AU$160m
Sep 30 2020	n/a	n/a	-AU$199m
Jun 30 2020	AU$3m	AU$2m	-AU$238m
Mar 31 2020	n/a	n/a	AU$34m
Dec 31 2019	n/a	n/a	AU$306m
Sep 30 2019	n/a	n/a	AU$291m
Jun 30 2019	AU$4m	AU$2m	AU$277m
Mar 31 2019	n/a	n/a	AU$270m
Dec 31 2018	n/a	n/a	AU$264m
Sep 30 2018	n/a	n/a	AU$255m
Jun 30 2018	AU$3m	AU$2m	AU$246m

Tazminat ve Piyasa: Dig 'nin toplam tazminatı ($USD 4.44M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 13.04M ).

Tazminat ve Kazançlar: Dig 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Dig Howitt (57 yo)

7.3yrs

Görev süresi

AU$6,446,856

Tazminat

Mr. Diggory William Howitt, also known as Dig, BE (Hons), MBA has been President of Cochlear Limited since July 31, 2017 and its Chief Executive Officer and Managing Director since January 3, 2018. Mr. How...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Diggory Howitt	CEO, MD	7.3yrs	AU$6.45m	0.094% $ 11.7m
Stuart Sayers	Chief Financial Officer	8.4yrs	AU$2.46m	0.0052% $ 648.1k
Jan Janssen	Chief Technology Officer	6.9yrs	AU$2.66m	0.0093% $ 1.2m
Karen O'Driscoll	Chief Information Officer	1.8yrs	Veri yok	Veri yok
Kristina Devon	Vice President of Investor Relations	no data	Veri yok	Veri yok
Rob McGrory	Group General Counsel & Company Secretary	1.1yrs	Veri yok	Veri yok
Jennifer Stevenson	VP of Corporate Communications & Brand	no data	Veri yok	Veri yok
Dean Phizacklea	Senior Vice President of Global Strategic Marketing	8.3yrs	Veri yok	Veri yok
Jennifer Hornery	Senior Vice President of Global People & Culture	7.8yrs	Veri yok	Veri yok
Greg Bodkin	Senior Vice President of Global Supply Chain	no data	Veri yok	Veri yok
Anthony Bishop	President of Asia Pacific & Latin America	no data	AU$1.45m	Veri yok
Kimberley Simpson	Head of Group Tax	no data	Veri yok	Veri yok

7.3yrs

Ortalama Görev Süresi

Deneyimli Yönetim: CHEO.F 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.3 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Diggory Howitt	CEO, MD	6.9yrs	AU$6.45m	0.094% $ 11.7m
Michael Daniell	Independent Non-Executive Director	4.8yrs	AU$295.72k	0.0025% $ 307.2k
Catriona Deans	Independent Non-Executive Chairman of the Board	9.8yrs	AU$596.78k	0.0069% $ 854.6k
Bruce Robinson	Independent Non-Executive Director	7.8yrs	AU$269.01k	0.0018% $ 225.1k
Karen Lee Penrose	Non-Executive Independent Director	2.3yrs	AU$305.87k	0.0022% $ 269.9k
Glen Boreham	Independent Non-Executive Director	9.8yrs	AU$293.36k	0.0046% $ 572.2k
Michael J. Del Prado	Independent Non-Executive Director	2.8yrs	AU$314.99k	0.0014% $ 179.1k
Christine McLoughlin	Independent Non-Executive Director	3.9yrs	AU$287.65k	0.0037% $ 456.5k
Caroline Clarke	Non-Executive Director	less than a year	Veri yok	Veri yok

4.8yrs

Ortalama Görev Süresi

61yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CHEO.F 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.8 yıldır).

Cochlear Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Stu Sayers to Appoint as President, Asia Pacific & Latin America of Cochlear Limited, Effective from 1 January 2025

Cochlear Limited Appoints Caroline Clarke as Non-Executive Director, Effective from 2 September 2024

Cochlear Limited Announces Executive Changes

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Cochlear Limited, Annual General Meeting, Oct 17, 2023

Recent updates

Stu Sayers to Appoint as President, Asia Pacific & Latin America of Cochlear Limited, Effective from 1 January 2025

Cochlear Limited Announces Ordinary Dividend for the Period of Six Months Ended June 30, 2024, Payable on October 10, 2024

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Cochlear Limited Appoints Caroline Clarke as Non-Executive Director, Effective from 2 September 2024

Cochlear Limited Announces Executive Changes

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old

Cochlear Limited Introduces Next Generation Cochlear Osia System with Ability to Have MRI at 3.0 T

Cochlear Limited to Report Fiscal Year 2024 Results on Aug 15, 2024

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Cochlear Limited Provides Earnings Outlook for the Year 2023

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Cochlear Limited, Annual General Meeting, Oct 17, 2023

FDA Approves Cochlear Limited's Nucleus 8 Sound Processor, Smaller, Smarter, Better Connected Cochlear Implant Technology

Cochlear Announces Final Dividend Payable on 17 October 2022

Cochlear Limited Appoints Karen Penrose to Board, Effective on 1 July 2022

Cochlear Limited, Annual General Meeting, Oct 18, 2022

Cochlear Limited to Report First Half, 2023 Results on Feb 15, 2023

Cochlear Limited Announces Interim Dividend Expected to Be Payable on 21 April 2022

FDA Approves Cochlear Nucleus Implants for Unilateral Hearing Loss/Single-Sided Deafness

Cochlear Limited Advises of US Patent Infringement Complaint

Sensorion and Cochlear to Begin First Clinical Trial of SENS-401 for Hearing Preservation in Combination with Cochlear Implantation

Cochlear Limited Provides Earnings Guidance for the Fiscal Year 2022

New Cochlear CoPilot app to help adults improve hearing outcomes through skills training

Cochlear Receives FDA Clearance of Baha 6 Max, Industry's Smallest 55 dB Sound Processor Now with Direct Android Streaming

Cochlear Limited Receives US Food and Drug Administration Approval for Baha 6 Max Sound Processor

Cochlear Limited Appoints Stu Sayers as Chief Financial Officer

Cochlear Limited Appoints Stu Sayers as Acting CFO

Cochlear Limited Appoints Stephen Mayne as Director

Cochlear Limited to Report Fiscal Year 2021 Results on Aug 20, 2021

Cochlear Limited to Report Fiscal Year 2020 Results on Aug 18, 2020

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş